IKS Health Q4 Revenue Jumps 18.5% YoY

IKS Health reported strong Q4 FY26 results with revenue of INR857 crores, up 18.5% YoY, and EBITDA of INR300 crores at 35% margin.
Management detailed progress on five strategic pillars, including AI-native agentic platform development and integration of the AQuity acquisition.
The company announced the acqui-hire of ARAI to advance glass box AI capabilities and provided updates on the pending TruBridge acquisition.
Full-year FY26 revenue reached INR3,193 crores with 20% YoY growth, while operating cash flow surged 99% to INR863 crores.